Antihistamine Switch Label Comprehension Studies Not Needed, FDA Says
This article was originally published in The Tan Sheet
Executive Summary
Label comprehension and actual use studies are not necessary for switching second-generation, Rx antihistamines OTC, FDA Division of Pulmonary & Allergy Drugs Director Robert Meyer, MD, said May 11.